Skip to main content
. 2023 Jun 21;12(13):4183. doi: 10.3390/jcm12134183

Table 1.

Population characteristics at the interview. Key to the table: All values refer to the person affected with SMA.

Caregiver (n = 150) Patients (n = 45)
All Adult (n = 72 ) Pediatric (n = 78) All Adult (n = 33) Pediatric (n = 12)
Patient’s age (years) 1 3–71
(20.18; 14.24)
18–71
(31.11; 13.32)
3–17
(10.08; 3.77)
14–62
(24.09; 10.22)
18–62
(27.18; 10.31)
14–17
(15.58; 0.99)
Gender 2 82 F (54.66%)
68 M (45.33%)
40 F (55.55%)
32 M (44.44%)
42 F (53.84%)
36 M (46.15%)
26 F (57.77%)
19 M (42.22%)
18 F (54.54%)
15 M (45.45%)
8 F (66.66%)
4 M (33.33%)
Sma Type 2
Sma Type II 90 (60.00%) 36 (50%) 54 (69.23%) 24 (53.33%) 17 (51.51%) 7 (58.33%)
Ambulant 0 (0.00%) 0 (0.00%) 0 (0.00%) 0 (0.00%) 0 (0.00%) 0 (0.00%)
Non Ambulant 90 (100.00%) 36 (100.00%) 54 (100.00%) 24 (100.00%) 17 (100%) 7 (100.00%)
Sma Type III 60 (40.00%) 36 (50%) 24 (30.76%) 21 (46.66%) 16 (48.48%) 5 (41.66%)
Ambulant 26 (43.33%) 11 (30.55%) 15 (62.5%) 13 (61.90%) 11 (68.75%) 2 (40%)
Non Ambulant 34 (56.66%) 25 (69.44%) 9 (37.5%) 8 (38.09%) 5 (31.25%) 3 (60%)

All values refer to the person affected with SMA. 1 Range (mean; standard deviation), 2 N (%); F = Female, M = Male.